Transcription of herpesvirus late genes depends on several virus-encoded proteins whose function is not completely understood. Here, we identify a viral trimeric complex of Kaposi's sarcoma-associated herpesvirus (KSHV) open reading frame 31 (ORF31), ORF24, and ORF34 that is required for late gene expression but not viral DNA replication. We found that (i) ORF34 bridges the interaction between ORF31 and ORF24, (ii) the amino-terminal cysteine-rich and carboxyl-terminal basic domains of ORF31 mediate the ORF31-ORF34 interaction required for late gene expression, and (iii) a complex consisting of ORF24, ORF31, and ORF34 specifically binds to the K8.1 late promoter. Together, our results support the model that a subset of lytic viral proteins assembles into a transcriptional activator complex to induce expression of late genes.
K
aposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) belongs to the gammaherpesvirus subfamily, which also includes Epstein-Barr virus (EBV) and murine gammaherpesvirus 68 (MHV-68). KSHV is etiologically linked to the AIDS-associated malignancy Kaposi's sarcoma, as well as two rare lymphoproliferative disorders, primary effusion lymphoma (PEL) and multicentric Castleman's disease (MCD) (1) . During the latent phase of infection, the KSHV genome is maintained as a circular episome in the nucleus (2) , where only a few genes are transcribed as part of the latency program (3, 4) . The lytic phase begins with the induction of immediate early (IE) genes, which in turn promotes the expression of early (E) genes (5) . The transcription of late genes depends on lytic replication of viral DNA, a process carried out by the core DNA replication machinery composed of KSHV-encoded proteins (6) . Chemical inhibitors of the herpesvirus-encoded DNA polymerase (e.g., phosphonoacetic acid [PAA] ) efficiently prevent expression of late genes but do not affect genes of the other kinetic classes (5) .
Several studies have begun to shed light on the regulation of late gene expression in beta-and gammaherpesviruses. Genetic studies of MHV-68 and EBV identified six gene products (open reading frame 18 [ORF18], -24, -30, -31, -34, and -66 in the case of KSHV), each of which is required for the transcription of late genes but dispensable for viral DNA replication and the expression of IE and E genes (7) (8) (9) (10) (11) . Many of these evolutionarily conserved genes of the beta-and gammaherpesviruses (␤-␥ genes) have since been shown to have similar effects on the gene expression of murine cytomegalovirus (MCMV) (12, 13) , human CMV (HCMV) (14) (15) (16) , and KSHV (17, 18) . Of note, none of these six ␤-␥ genes are found in the alphaherpesvirus subfamily, suggesting that a mechanistically distinct process controls late gene expression in the alpha subfamily. Recent studies suggest that the ␤-␥ gene products assemble into a viral preinitiation complex (vPIC) that also includes RNA polymerase II (RNAPII) (11, 18) . One of the vPIC components is ORF24, which was identified as a viral protein distantly related to the cellular TATA box binding protein (TBP), and has been shown to bind DNA and RNAPII (18) (19) (20) .
Relatively less is known about the individual functions of the other vPIC components. In order to define the function of the vPIC subunit ORF31, we constructed a recombinant KSHV (called 31S) which harbors a premature stop codon and frameshift mutation within ORF31 (Fig. 1A and Table 1 ). To control for the possibility of unintended second-site mutations, we constructed a revertant virus in which the wild-type (WT) ORF31 sequence was restored (Table 1) . Because we failed to generate ORF31 antibody, the 3ϫFLAG coding sequence was introduced at the 3= end of the gene to be able to detect the protein in infected cells (Table 1 ). All recombinants were verified by pulsed-field gel electrophoresis, PCR, and sequencing as published before (21; data not shown). We established stable iSLK cell lines carrying each recombinant virus, and infectious virus production was assayed as previously described (21, 22) . While WT and revertant iSLK cell lines yielded readily detectable infectious virus, iSLK-31S cells failed to yield detectable progeny virus (Fig. 1B) , consistent with the described role of its orthologs in other herpesviruses (7, 13, 16) . Immunoblot analysis showed that, compared to WT and revertant viruses, ORF31-deficient virus was specifically defective in the expression of the late gene ORF8 but not in the expression of latent (LANA) or E (K3) genes or in replication of viral DNA (Fig. 1C and D) . Although the 31S, revertant, and 3ϫFLAG cell lines had reduced RTA expression compared to the WT (Fig. 1C) , the levels of induction of viral DNA replication were comparable in these cell lines (Fig. 1D ), indicating that they expressed an amount of RTA sufficient for lytic reactivation. It is important to note that the 3= end of the ORF31 coding sequence overlaps the 5= end of ORF32, a gene encoding a capsid-associated tegument protein that is homologous to members of the UL17 family of genes (23) . UL17 of herpes simplex virus 1 (HSV-1) is essential for DNA packaging into the capsid and, thus, infectious virus production (24) . Thus, the ORF31-3ϫFLAG recombinant failed to produce infectious progeny (Fig. 1B) , most likely because the ORF32 gene is disrupted by the 3ϫFLAG epitope tag. Importantly, levels of lytic gene expression and DNA replication were comparable between the ORF31-3ϫFLAG and WT viruses, indicating that the lytic gene expression cascade was intact in the ORF31-3ϫFLAG virusinfected cells (Fig. 1C and D and data not shown).
To determine whether ORF31 deficiency had a global effect on viral gene expression, we took advantage of NanoString technology, a hybridization-based method sensitive enough to detect RNA without an amplification step. It relies on two probes: a capture probe, which allows immobilization of the target mRNA and imaging on a solid surface, and a reporter probe, which is linked to a color-coded identifier for each gene of interest (25) . We designed a customized panel of probes to quantify viral transcript levels across the entire KSHV genome. Total RNA was isolated from induced iSLK-WT and iSLK-31S cells at 48 h postinduction (p.i.) and submitted for NanoString analysis. The data show a widespread reduction in viral transcript levels in ORF31-deficient cells compared to levels in WT-infected cells (Fig. 2) . ORF31 deficiency preferentially impacted the expression of late genes; K8.1, ORF52, ORF17, ORF39, ORF8, and ORF43 were among the top 10 genes with the highest fold reduction in expression (Fig. 2) . In contrast, the data show a less dramatic effect on immediate early (e.g., ORF50) and early (e.g., K2, K3, K7, and ORF70) gene expression. Interestingly, the lack of ORF31 resulted in a modest upregulation of the expression of some genes, including ORF67A, K12, ORF18, and ORF59, suggesting a potential role for ORF31 as a negative as well as a positive regulator of viral gene expression.
To gain further insight into the role of ORF31 during KSHV lytic replication, we performed a single-step FLAG purification using whole-cell lysates (WCL) of induced iSLK-BAC16-ORF31-3ϫFLAG cells. iSLK-BAC16-K4.2-3ϫFLAG cells served as a control (Fig. 3A) . Mass spectrometry analysis revealed many ORF31-binding proteins, including those of ORF24 and ORF34, genes whose orthologs are required for late gene expression in other herpesviruses, including HCMV (14), MHV-68 (9, 10), and KSHV (18) (Fig. 3A) . This finding is in agreement with a recent report showing that the EBV equivalents of ORF18, ORF24, ORF30, ORF31, ORF34, and ORF66, when coexpressed in HEK293 cells, assemble into a functional complex, termed vPIC, that controls late gene transcription (11) . In order to demonstrate whether ORF24, -31, and -34 assemble when endogenously ex- (21) via a single application of a two-step homologous-recombination procedure (27, 28) , resulting in a frameshift mutation, a premature amber codon, and a new restriction enzyme recognition site (underlined). (B) Naive 293A cells were inoculated with cell-free supernatants harvested from each of the indicated lytically induced cultures of iSLK-BAC stable cell lines. Virus was produced by inducing 3 ϫ 10 6 of each iSLK cell line with 1 g/ml doxycycline and 1.2 mM sodium butyrate for 72 h. Infectious virus was quantified by flow cytometry of infected 293A cells at 24 h p.i. using the BAC16-encoded constitutively expressed GFP marker. APC, antigen-presenting cells. (C) iSLK cells carrying the different recombinant KSHVs were induced for 1/2, 1, 2, or 3 days with doxycycline and sodium butyrate as described above, and protein levels in whole-cell lysates were analyzed by immunoblotting using the indicated antibodies. (D) Relative amounts of viral DNA were quantified using ORF11-specific primers as previously described (21) . The graph shows fold changes in viral DNA copy number relative to numbers in untreated WT-infected cells.
pressed in KSHV-infected cells, we modified the ORF31-3ϫFLAG KSHV BACmid to include additional epitope tags: a C-terminal three-hemagglutinin (3ϫHA) tag for ORF24 and an N-terminal V5 tag for ORF34 (Table 1) . To facilitate generation of the PCR product for recombination, the 3ϫHA and 3ϫFLAG coding sequences were cloned into the unique NheI site adjacent to aphAI of pEP-CMV-in, resulting in pEP-3ϫFLAG-in and pEP-3ϫHA ( Table 1 ). The triply tagged BACmid (termed FHV for FLAG, HA, and V5) was verified as described above (data not shown). Immunoblot analysis revealed that ORF24, -31, and -34 were first detectable at 24 h p.i., just prior to the onset of viral DNA replication (data not shown), and reached peak levels between 48 and 60 h p.i. (Fig. 3B) . ORF24, ORF31, and, to a lesser extent, ORF34 were sensitive to PAA treatment, suggesting that they are expressed as ␥-1 late genes or "leaky" late genes (i.e., they are expressed prior to viral DNA replication, but their expression is significantly enhanced by viral DNA replication) (Fig. 3B) .
FLAG immunoprecipitation from lytically induced iSLK-FHV cells confirmed that endogenous ORF31 specifically associates with ORF24 and ORF34 but not another viral nuclear protein, LANA (Fig. 3C) . Next, we transfected ORF24-HA-, ORF31-3ϫFLAG-, and ORF34-V5-expressing plasmids in different combinations into HEK293T cells to assess the interaction of individual components of this complex (Fig. 3D to F) . We found that ORF31 could efficiently interact with ORF34 ( Fig. 3D ) but failed to interact with ORF24 in the absence of ORF34 (Fig. 3F, lanes 1 to 4) . On the other hand, ORF24 and ORF34 could efficiently interact (Fig. 3E) , and coexpression of ORF34 was necessary and sufficient for the ability of ORF24 to coprecipitate with ORF31 (Fig. 3F, lane 5) . Increasing ORF34 expression levels resulted in a dose-dependent increase in the efficiency with which ORF31 associated with ORF24, indicating that ORF34 bridges the interaction between ORF31 and ORF24 (Fig. 3F, lanes 5 to 7) . To determine whether the ORF24-ORF31-ORF34 complex binds to late promoters dur- 
FIG 2
Genome-wide analysis of KSHV transcripts using NanoString technology. iSLK cells harboring WT or ORF31-deficient virus were lytically induced for 48 h as described for Fig. 1 above. RNA was isolated by Tri Reagent (Life Technologies), which was followed by column purification (RNeasy minikit [Qiagen] ). Viral mRNA expression was analyzed by an nCounter analysis system using nSolver analysis software 2.0 (NanoString Technologies). The graph shows fold changes in viral transcript levels of ORF31-deficient KSHV relative to transcript levels of the WT.
ing lytic reactivation, we performed chromatin immunoprecipitation assays using lytically induced iSLK-BAC16-FHV cells and antibodies against the epitope-tagged viral proteins (Fig. 3G) . We found that ORF24, -31, and -34 were specifically recruited to the promoter of K8.1 (a late gene) but not that of ORF56 or K2 (early genes). This recruitment was concomitant with the binding of activated RNAPII at 48 h p.i. Taken together, these data indicate that ORF24, -31, and -34 form a complex during lytic reactivation and specifically bind to KSHV late promoters, which is consistent with their function as transcriptional activators of late genes. K4.2-FLAG recombinant viruses were treated with 1 g/ml doxycycline and 1.2 mM sodium butyrate. Two days postinduction, cells were collected, whole-cell lysates were subjected to FLAG immunoprecipitation, and precipitates were separated by SDS-PAGE. Proteins were detected by silver staining and identified by mass spectrometry. Arrowhead 1, ORF24; arrowhead 2, ORF66; arrowhead 3, ORF34; and arrowhead 4, ORF31. Lane M, molecular mass markers (in kilodaltons). (B) iSLK-FHV cells harboring the triply tagged recombinant virus encoding epitope-tagged versions of ORF24, ORF31, and ORF34 were induced for the indicated numbers of hours postinduction (HPI) in the presence or absence of 0.5 mM phosphonoacetic acid (PAA). Whole-cell lysates were analyzed by immunoblotting with the indicated antibodies. vIL-6, viral interleukin 6. (C) iSLK-FHV cells were induced for 48 h in the presence or absence of PAA as described above. WCL were used for FLAG immunoprecipitation (IP) followed by immunoblotting with the indicated antibodies. (D) HEK293T cells were cotransfected with ORF31-3ϫFLAG and/or ORF34-V5 as indicated. WCL were used for immunoprecipitation with V5 antibody followed by immunoblotting with the indicated antibodies. (E) HEK293T cells were cotransfected with ORF24-3ϫHA and/or ORF34-V5 as indicated. WCL were used for immunoprecipitation with V5 antibody followed by immunoblotting with the indicated antibodies. (F) HEK293T cells were cotransfected with ORF24-3ϫHA, ORF31-3ϫFLAG, and/or ORF34-V5 as indicated. WCL were used for immunoprecipitation with FLAG antibody followed by immunoblotting with the indicated antibodies. (G) Chromatin immunoprecipitation (ChIP) assay. iSLK-FHV and iSLK-BAC16-WT cells were treated with 1 g/ml doxycycline and 1.2 mM sodium butyrate for 48 h. The iSLK-BAC16-WT cells lacking the epitope tag (WT) were used as a negative control. ChIP was performed using antibodies for HA, FLAG, V5, and RNAPII phosphorylated at serine 5 within its C-terminal domain. ChIP DNA was quantified by quantitative PCR with primers specific to the core promoter regions of the indicated genes. Data were normalized to the level of input DNA and are presented as percentages of the input, as previously described (3).
Having identified ORF34 as likely the most directly interacting partner of ORF31, we then constructed a series of FLAG-tagged ORF31 truncation mutants to define the domains responsible for its interaction with ORF34. ORF31 harbors an amino-terminal cysteine-rich (CR) region, a middle domain (Mid), and a carboxylterminal basic domain (BD) (Fig. 4A) . FLAG immunoprecipitation showed that the CR and BD regions of ORF31 were individually sufficient for ORF34 association, and thus the deletion of either the CR or BD region resulted in diminished binding to ORF34 (Fig. 4B) . In order to address how diminished binding between ORF31 and ORF34 affects late gene expression, we used our red-green-blue-BAC16 (RGB-BAC16), which harbors a K8.1 promoter-driven TagBFP expression cassette as well as a pPANdriven enhanced-green fluorescent protein (EGFP) cassette (22) . We constructed an RGB-BAC16-ORF31-Stop recombinant KSHV and introduced it into iSLK cells to make a stable cell line as described previously (21; data not shown). Following 72 h of induction with doxycycline and sodium butyrate, vector-transduced iSLK-RGB-31S cells failed to express blue fluorescent protein (BFP), while cells expressing full-length ORF31 showed significant expression of BFP, as expected ( Fig. 4C and D) . Transduction with ORF31 mutants lacking the ability to bind ORF34 failed to rescue BFP expression. Interestingly, the Mid deletion mutant was also unable to induce expression of BFP, despite the fact that it efficiently binds to ORF34 (Fig. 4B to D) . This suggests that the Mid domain of ORF31 may have additional roles, such as binding other viral or cellular components of the vPIC. One possibility is that it mediates an interaction between ORF31 and ORF18. In fact, M92, the MCMV equivalent of ORF31, was shown to interact with M79, the MCMV homolog of KSHV ORF18 (13) . Taken together, our data demonstrate that during lytic reactivation, KSHV ORF24, -31, and -34 assemble into a viral complex in which ORF34 acts as a bridging factor between ORF31 and ORF24. This complex associates specifically with late gene promoters and is critical for the expression of late genes. Our study is in agreement with previous work showing that the EBV homologs of ORF18, -24, -30, -31, -34, and -66 form a large complex that includes RNA polymerase II (RNAPII) and was termed the viral preinitiation complex (vPIC), which is involved in the expression of late genes (11) . In addition, yeast two-hybrid data from the Haas study shows an interaction between ORF31 and another vPIC component, ORF30 (26) . A recent report on the KSHV-host interactome provides additional insight into the composition of the vPIC; mass spectrometry analysis identified HDAC1, PABP4, PABP5, and an RNAPII subunit (RPB2) as putative ORF31-binding partners (18) . While many herpesviral genes required for late gene expression have been identified, the host factors binding to viral vPIC proteins and their role in vPIC are still largely unknown. Thus, future studies will clarify the emerging architecture of the vPIC and provide a better mechanistic understanding of the regulation of late gene expression in beta-and gammaherpesviruses.
